Faculty Disclosures
| Mitchell S. Elkind, MD, MS, FAAN |
Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy. |
| Oscar R. Benavente, MD, FRCP(C) |
No disclosure on file
|
| Ralph L. Sacco, MD, MS, FAHA |
Dr. Sacco has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Sacco has received research support from NIH, NINDS, NCATS, NIMHD. The institution of Dr. Sacco has received research support from FL Department of Health. Dr. Sacco has received research support from University of Washington, Seattle. Dr. Sacco has received publishing royalties from a publication relating to health care. |
| Massimo Pandolfo, MD, FAAN |
Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Bio. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to AAN interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with AAN that is relevant to AAN interests or activities. |
| Diana Apetauerova, MD |
No disclosure on file
|
| Yannick Bejot |
No disclosure on file
|
|
No disclosure on file
|
| Maurice Giroud |
No disclosure on file
|
| Guy Victor Osseby, MD |
No disclosure on file
|
| Benjamin R. Brooks, MD, FAAN |
Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with 好色先生 that is relevant to AAN interests or activities. |
| Scott L. Silliman, MD |
Dr. Silliman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. |
| Souvik Sen, MD, MS |
Dr. Sen has nothing to disclose. |
| Patrice Laloux, MD |
No disclosure on file
|
| Serge A. Blecic, MD, PhD |
No disclosure on file
|
| Philippe Desfontaines, MD |
No disclosure on file
|
| Jean Jacquy |
No disclosure on file
|
| Sandrine Jeangette |
No disclosure on file
|
| Sherine Abboud, MD, PhD |
No disclosure on file
|
| Bernadette Boden-Albala, DrPH |
Ms. Boden-Albala has received research support from NIH. |
| Stephen M. Oppenheimer, MD, FRCP |
No disclosure on file
|
| Raji P. Grewal, MD, FAAN |
No disclosure on file
|
| Leema Peddareddygari, MBBS |
No disclosure on file
|
| Joshua Z. Willey, MD |
Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edwards Scientific. Dr. Willey has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RECARDIO. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainQ. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the American College of Cardiology. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Uptodate. The institution of Dr. Willey has received research support from NIH. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Review chapter author, MKSAP 16-20 with American College of Physicians. |
| Lucas Restrepo, MD, PhD |
Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care. |
| Amber L. Ward |
No disclosure on file
|
| Natalya Shneyder, MD |
Dr. Shneyder has nothing to disclose. |
| Henrik Zetterberg |
Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions. |
| Rene A. Colorado, MD |
No disclosure on file
|
| Paul Mehta |
Paul Mehta has nothing to disclose. |
| Elena Bravver, MD |
No disclosure on file
|
| Samir Alkabie, MD, MSc |
Dr. Alkabie has nothing to disclose. |
| Mohammed S. Sanjak, PhD |
No disclosure on file
|
| Andre P. Matta, MD |
Dr. Matta has received personal compensation for serving as an employee of Sanofi. Dr. Matta has received stock or an ownership interest from Sanofi. |
| Camila Pupe, MD |
Dr. Pupe has nothing to disclose. |
| Joanna Dojillo, MSc |
No disclosure on file
|
| Priscilla C. Russo |
No disclosure on file
|
| Kazuko Matsuda, MD |
No disclosure on file
|
| Alonso Morales-Rivero, MD |
No disclosure on file
|
| Monica M. Chavarria, MD |
No disclosure on file
|
| Mary-Ann Fares, MD |
No disclosure on file
|
| Kwo Wei David Ho, MD, PhD |
No disclosure on file
|
| Henrique J. Prado, MD |
No disclosure on file
|
| Bianca L. Aleixo, MD |
No disclosure on file
|
| Tayla T. Romao, Sr., MD |
No disclosure on file
|
| Yuichi Iwaki |
No disclosure on file
|
| Ramesh Konanki, MD |
No disclosure on file
|
| Vincent Picher-Martel, MD |
Dr. Picher-Martel has nothing to disclose. |
| Shruthi N M, DM |
No disclosure on file
|
| Vladana Markovic |
No disclosure on file
|
| Jessica Z. Lee |
No disclosure on file
|
| Lokesh Saini, DM |
Dr. Saini has nothing to disclose. |
| Akshay Deepak, MD |
Dr. Deepak has nothing to disclose. |
| Manoj K. Singh II, MD |
No disclosure on file
|